Co-investment Platform with Reduced Risk and Unmatched Liquidity
Focus and Guidelines
We are well-positioned to achieve venture returns with reduced risk and higher liquidity by investing in mid- to late-stage venture-backed healthcare companies, while also capitalizing on Asia's robust healthcare demand for the U.S.’s advanced technology to strategically create value for our portfolio companies. Our structure gives our investors the option to participate at their sole discretion in each fully underwritten deal led by a prestigious venture capital firm, providing unmatched flexibility and transparency.
Revenue > US$20 million
Annual top line growth over 40%
Global investments with a focus on product/service commercialization in Asia
Profitability & Cash Flow
EBITDA > US$ 2 million
Capital raised should fund operations for at least 3 years
Men's & Women's Health
Active Involvement in Deal Lifecycle
Comprehensive and detail-oriented value-creation strategy ensures our participation in the full private equity investment process ─ from deal-sourcing to exit strategy.
Abundant connections and resources in the United States healthcare and finance industries strongly support investment deal-sourcing
Deep experience in cross-border commercialization and operational management help to create value for portfolio companies
Vast network of medical and financial institutions will provide a multi-faceted exit strategy ranging from traditional IPO to strategic sales and SPACs